2001 Media releases

12/14/01	Important Public Warning - Recall of Transderm-Nitro^® 0.4 - Lot S68000
12/10/01	Femara^® (letrozole) Data Demonstrate Survival Advantage Compared to Tamoxifen in First-Line Hormonal Treatment of Postmenopausal Women with Advanced Breast Cancer
12/06/01	New England Journal of Medicine Study Demonstrates Important Role for Diovan^® (valsartan) in Treatment of Heart Failure
12/05/01	Health Canada grants Priority Review to Novartis Pharmaceuticals Canada Inc.'s Gleevec^® in the treatment of malignant gastrointestinal stromal tumors (GIST)
10/04/01	Comtan^® for Parkinson's Disease Now Available in Canada
09/24/01	Health Canada Approves Unique Leukemia Medication, Gleevec, Following Priority Review
05/23/01	Femara Approved as First-Line Treatment of Advanced Breast Cancer Following Priority Review by Health Canada
03/19/01	Novartis Pharmaceuticals Canada Inc. Announces Long-Term Supply Agreement with Patheon Inc.
01/16/01	Alberta Celebrates Alzheimer Awareness Month this January with Announcement that New Treatment, Exelon^®, is Now Covered on Provincial Drug Plan